Tema Heart & Health ETFTema Heart & Health ETFTema Heart & Health ETF

Tema Heart & Health ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪48.76 M‬USD
Fund flows (1Y)
‪−28.32 M‬USD
Dividend yield (indicated)
0.47%
Discount/Premium to NAV
−0.2%
Shares outstanding
‪1.60 M‬
Expense ratio
0.75%

About Tema Heart & Health ETF


Issuer
Dawn Global Topco Ltd.
Brand
Tema
Home page
Inception date
Nov 21, 2023
Structure
Open-Ended Fund
Index tracked
No Underlying Index
Replication method
Physical
Management style
Active
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Tema ETFs LLC
Distributor
Foreside Fund Services LLC
ISIN
US87975E8839
HRTS seeks long-term capital growth by targeting 15 to 100 pure-play companies at the forefront of combating diabetes, obesity, and cardiovascular diseases. This includes companies engaged in pharmaceuticals, emerging biotech, medical devices, and healthcare service providers. The fund aims to identify growth opportunities within the thematic universe, employing a dual-pronged approach involving top-down fundamental sector research and quantitative tools, as well as bottom-up security analysis. As part of the strategy, ESG factors are integrated to maximize returns and control risks. It utilizes a thorough analysis approach that combines internal research, external resources, and thematic strategies to pinpoint attractive investment opportunities. While holdings may include global stocks, a significant portion is expected to be directed toward the US and Europe. The fund may enter lending transactions.

Broaden your horizons with more funds linked to HRTS via country, focus, and more.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Active
Geography
Global
Weighting scheme
Proprietary
Selection criteria
Proprietary
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
76%21%1%
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
HRTS trades at 30.30 USD today, its price has fallen −0.41% in the past 24 hours. Track more dynamics on HRTS price chart.
HRTS net asset value is 30.37 today — it's risen 2.11% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
HRTS assets under management is ‪48.76 M‬ USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
HRTS price has risen by 3.24% over the last month, and its yearly performance shows a −11.25% decrease. See more dynamics on HRTS price chart.
NAV returns, another gauge of an ETF dynamics, showed a 6.62% increase in three-month performance and has decreased by −9.17% in a year.
HRTS fund flows account for ‪−28.32 M‬ USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
HRTS invests in stocks. See more details in our Analysis section.
HRTS expense ratio is 0.75%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, HRTS isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, HRTS technical analysis shows the buy rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating HRTS shows the neutral signal. See more of HRTS technicals for a more comprehensive analysis.
Yes, HRTS pays dividends to its holders with the dividend yield of 0.47%.
HRTS trades at a premium (0.22%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
HRTS shares are issued by Dawn Global Topco Ltd.
HRTS follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Nov 21, 2023.
The fund's management style is active, aiming to outperform its benchmark index by actively selecting and adjusting assets. The goal is to achieve returns that exceed those of the index the fund tracks.